Eisai Company, Ltd. Announces Completion of Tender Offer for MGI PHARMA, INC. Shares

Published: Jan 28, 2008

TOKYO--(BUSINESS WIRE)--Eisai Co., Ltd. (Tokyo, TSE 4523) (“Eisai”), a research-based human health care (hhc) company, today announced the completion of the offer by its indirect wholly-owned subsidiary, Jaguar Acquisition Corp. (“Jaguar”), to purchase all outstanding shares of the common stock of MGI PHARMA, INC. (NASDAQ: MOGN) (“MGI PHARMA”), including the associated preferred share purchase rights, for US$41.00 per share, without interest and subject to applicable withholding of taxes. As of 12:00 midnight (New York City time) on Friday, January 25, 2008, the expiration date of the previously announced subsequent offering period for the offer, 76,494,076 MGI PHARMA shares have been validly tendered into the offer, representing over 93.8% of the outstanding shares of MGI PHARMA. All shares validly tendered in the offer have been accepted for payment, and the consideration for all such shares either has been paid or will promptly be paid.

Back to news